This is in line with previous observations that a negative ANA test does not reliably indicate the absence of circulating autoantibodies such as myositis-specific autoantibodies and should not be considered as definitively excluding an underlying CTD (10, 34, 35). The gene discussed is BTG3; the disease is myositis disease.